Withings BPM Connect

DEVICE3 trials

Sponsors

Leiden University Medical Center, University Medical Center Groningen

Conditions

AlbuminuriaCKDCKD Stage 3CKD Stage 4Chronic Kidney Disease Due to Type 2 Diabetes MellitusChronic Kidney Disease stage3Chronic Kidney Disease stage4Chronic Kidney Diseases

Phase 4

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

CompletedNCT06094920

University Medical Center GroningenAlbuminuria, Chronic Kidney Disease Due to Type 2 Diabetes Mellitus, Chronic Kidney Diseases +10

Start: 2024-07-29End: 2025-09-24Updated: 2026-02-13

Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.

CompletedNCT06374043

University Medical Center GroningenAlbuminuria, Chronic Kidney Disease Due to Type 2 Diabetes Mellitus, Chronic Kidney Diseases +7

Start: 2021-05-11End: 2022-09-13Updated: 2024-04-22

Unknown Phase

The ICU-recover Box, Using Smart Technology for Monitoring Health Status After ICU Admission

CompletedNCT05766319

Leiden University Medical CenterCritically Ill, ICU Survivor, User Experience

Start: 2022-09-26End: 2024-05-31Updated: 2024-06-14

Related Papers

Feasibility of Decentralised Response-Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease.

2026-07-30